Filing Flows › Jazz Pharmaceuticals (JAZZ) › Net income
Jazz Pharmaceuticals (JAZZ) net income by quarter
Jazz Pharmaceuticals' net income was $193M in Q2 2026 (second quarter 2026), -34% from Q1 2026. Over the last 4 quarters it ranged from $193M (Q2 2026) to $293M (Q1 2026).
| Quarter | Net income | Q/Q | Y/Y |
|---|---|---|---|
| Q2 2026 | $193M | -34% | — |
| Q1 2026 | $293M | +44% | — |
| Q4 2025 | $203M | -19% | — |
| Q3 2025 | $251M | — | — |
Q2 2026 at a glance
Jazz Pharmaceuticals, Q2 2026: revenue $1.2B (+16% year over year), operating margin 20.5%, net earnings $193M, operating cash flow $416M. The chart follows the revenue to costs, profit and cash.
Questions
What is Jazz Pharmaceuticals' net income?
Jazz Pharmaceuticals' net income was $193M in Q2 2026 (second quarter 2026), -34% from Q1 2026.
How has Jazz Pharmaceuticals' net income changed?
Over the last 4 quarters it ranged from $193M (Q2 2026) to $293M (Q1 2026).